使用7-deaza-7-fluoro-2'-C-methyladenosine对抗黄热病病毒
Julia C LeCher1, Vivian Vasconcelos Costa2, Lauren N Rust3
1Center for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
Antimicrobial agents and chemotherapy
|April 14, 2025
概括
一种新型化合物,7-deaza-7-fluoro-2'-C-methyladenosine (DFA),显示出强大的潜力作为抗病毒治疗黄热病病毒 (YFV). 在临床前模型中,这种药物有效地减少了YFV复制和肝损伤.
科学领域:
- 病毒学 病毒学
- 传染性疾病 传染性疾病
- 药物发现 药物发现 药物发现
背景情况:
- 黄热病病毒 (YFV) 是一种严重的动物性黄热病病毒,没有经批准的抗病毒治疗方法.
- YFV是由非洲和南美洲热带地区的蚊子传播的.
- 之前的研究已经确定了7-deaza-7-fluoro-2 -C-methyladenosine (DFA) 作为一种潜在的YFV抑制剂.
研究的目的:
- 评估DFA的抗病毒活性,特别是针对YFV.
- 为了评估DFA的疗效和安全性,在体外和体内.
主要方法:
- 在体外测试中使用YFV疫苗菌株 (YFV-17D) 和临床分离物 (DakH1279) 进行了体外测试.
- 在活体中,有效性在感染YFV的A129和AG129小鼠模型中进行了测试.
- 测量了肝损伤的关键指标,包括氨酸转氨酶水平和氨酸绿色清除值.
主要成果:
- DFA在体外表现出强大的亚微分子活性对抗YFV,细胞毒性较低.
- DFA显著减少了感染小鼠肝脏中的病毒复制.
- 用DFA治疗改善了YFV诱导的肝损伤标志物在体内.
结论:
- DFA是黄热病病毒的强有力的抑制剂.
- 作为治疗YFV感染的治疗剂,DFA显示出前景.
- 进一步开发DFA作为泛病毒治疗药物是有必要的.
相关概念视频
Yellow Fever
Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...


